Diabetic Microangiopathy: Impact of Impaired Cerebral Vasoreactivity and Delayed Angiogenesis After Permanent Middle Cerebral Artery Occlusion on Stroke Damage and Cerebral Repair in Mice

Diabetes increases the risk of stroke by three, increases related mortality, and delays recovery. We aimed to characterize functional and structural alterations in cerebral microvasculature before and after experimental cerebral ischemia in a mouse model of type 1 diabetes. We hypothesized that preexisting brain microvascular disease in patients with diabetes might partly explain increased stroke severity and impact on outcome. Diabetes was induced in 4-week-old C57Bl/6J mice by intraperitoneal injections of streptozotocin (60 mg/kg). After 8 weeks of diabetes, the vasoreactivity of the neurovascular network to CO2 was abolished and was not reversed by nitric oxide (NO) donor administration; endothelial NO synthase (eNOS) and neuronal NO synthase (nNOS) mRNA, phospho-eNOS protein, nNOS, and phospho-nNOS protein were significantly decreased; angiogenic and vessel maturation factors (vascular endothelial growth factor a [VEGFa], angiopoietin 1 (Ang1), Ang2, transforming growth factor-β [TGF-β], and platelet-derived growth factor-β [PDGF-β]) and blood-brain barrier (BBB) occludin and zona occludens 1 (ZO-1) expression were significantly decreased; and microvessel density was increased without changes in ultrastructural imaging. After permanent focal cerebral ischemia induction, infarct volume and neurological deficit were significantly increased at D1 and D7, and neuronal death (TUNEL+/NeuN+ cells) and BBB permeability (extravasation of Evans blue) at D1. At D7, CD31+/Ki67+ double-immunolabeled cells and VEGFa and Ang2 expression were significantly increased, indicating delayed angiogenesis. We show that cerebral microangiopathy thus partly explains stroke severity in diabetes.

[1]  K. Porter,et al.  The vascular smooth muscle cell: a therapeutic target in Type 2 diabetes? , 2013, Clinical science.

[2]  Taku Sugawara,et al.  Temporal profile of angiogenesis and expression of related genes in the brain after ischemia , 2004 .

[3]  M. Moskowitz,et al.  L-NNA-sensitive regional cerebral blood flow augmentation during hypercapnia in type III NOS mutant mice. , 1996, The American journal of physiology.

[4]  P. Abraham,et al.  Aldose Reductase Pathway Inhibition Improved Vascular and C-Fiber Functions, Allowing for Pressure-Induced Vasodilation Restoration During Severe Diabetic Neuropathy , 2006, Diabetes.

[5]  A. Ergul,et al.  Cerebral Neovascularization and Remodeling Patterns in Two Different Models of Type 2 Diabetes , 2013, PloS one.

[6]  Emiri T. Mandeville,et al.  Deficient eNOS Phosphorylation Is a Mechanism for Diabetic Vascular Dysfunction Contributing to Increased Stroke Size , 2013, Stroke.

[7]  C. Watala,et al.  Effect of natural polyphenols, pycnogenol® on superoxide dismutase and nitric oxide synthase in diabetic rats. , 2010, Prague medical report.

[8]  P. Gressens,et al.  Dual action of NO synthases on blood flow and infarct volume consecutive to neonatal focal cerebral ischemia , 2012, Experimental Neurology.

[9]  W. Sessa,et al.  Regulation of endothelium-derived nitric oxide production by the protein kinase Akt , 1999, Nature.

[10]  Jon Andresen,et al.  Endothelial influences on cerebrovascular tone. , 2006, Journal of applied physiology.

[11]  Barney M. Berlin,et al.  Size , 1989, Encyclopedia of Evolutionary Psychological Science.

[12]  B. Lévy,et al.  Glatiramer Acetate administration does not reduce damage after cerebral ischemia in mice , 2013, Journal of Neuroimmunology.

[13]  A. Ergul,et al.  Cerebrovascular complications of diabetes: focus on stroke. , 2012, Endocrine, metabolic & immune disorders drug targets.

[14]  Nathalie Kubis,et al.  Neuroblast survival depends on mature vascular network formation after mouse stroke: role of endothelial and smooth muscle progenitor cell co‐administration , 2012, The European journal of neuroscience.

[15]  D. Ziegler,et al.  Stroke in patients with diabetes mellitus , 2004, Diabetes/metabolism research and reviews.

[16]  D. Henrion,et al.  Endothelial Nitric Oxide Synthase Lies Downstream From Angiotensin II–Induced Angiogenesis in Ischemic Hindlimb , 2002, Hypertension.

[17]  C. Sartori,et al.  Central Insulin Regulates Heart Rate and Arterial Blood Flow , 2007, Diabetes.

[18]  B. Palmier,et al.  Reduction of hemorrhagic transformation by PJ34, a poly(ADP-ribose)polymerase inhibitor, after permanent focal cerebral ischemia in mice. , 2008, European journal of pharmacology.

[19]  P. Dyck,et al.  Ultrastructural morphometric abnormalities of sural nerve endoneurial microvessels in diabetes mellitus , 1994, Annals of neurology.

[20]  Peter Libby,et al.  Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. , 2002, JAMA.

[21]  J. van de Voorde,et al.  Endothelial dysfunction in diabetes , 2000, British journal of pharmacology.

[22]  P. Gressens,et al.  Nitric oxide signaling in the brain: A new target for inhaled nitric oxide? , 2013, Annals of neurology.

[23]  Y. Yoon,et al.  Dual Angiogenic and Neurotrophic Effects of Bone Marrow–Derived Endothelial Progenitor Cells on Diabetic Neuropathy , 2009, Circulation.

[24]  R. Albrecht,et al.  The Role of Endothelium and Nitric Oxide in Rat Pial Arteriolar Dilatory Responses to CO2 in vivo , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[25]  M. Pocard,et al.  Impact of intracranial blood-flow redistribution on stroke size during ischemia–reperfusion in 7-day-old rats , 2011, Journal of Neuroscience Methods.

[26]  R. Panerai,et al.  Cerebral blood flow response to neural activation after acute ischemic stroke: a failure of myogenic regulation? , 2013, Journal of Neurology.

[27]  N. Castanon,et al.  Cognitive and Emotional Alterations Are Related to Hippocampal Inflammation in a Mouse Model of Metabolic Syndrome , 2011, PloS one.

[28]  G. Christoforidis,et al.  Angiographic assessment of pial collaterals as a prognostic indicator following intra-arterial thrombolysis for acute ischemic stroke. , 2005, AJNR. American journal of neuroradiology.

[29]  A. Ergul,et al.  Hyperglycemia, diabetes and stroke: focus on the cerebrovasculature. , 2009, Vascular pharmacology.

[30]  S. Fukumoto,et al.  Receptor for Advanced Glycation End Products Is Involved in Impaired Angiogenic Response in Diabetes , 2006, Diabetes.

[31]  M. Chopp,et al.  Angiopoietin/Tie2 pathway mediates type 2 diabetes induced vascular damage after cerebral stroke , 2011, Neurobiology of Disease.

[32]  A. Ergul,et al.  Enhanced Cerebral but Not Peripheral Angiogenesis in the Goto-Kakizaki Model of Type 2 Diabetes Involves VEGF and Peroxynitrite Signaling , 2012, Diabetes.

[33]  P. Hardy,et al.  Prolonged Hypercapnia-Evoked Cerebral Hyperemia via K+ Channel– and Prostaglandin E2–Dependent Endothelial Nitric Oxide Synthase Induction , 2000, Circulation research.

[34]  R. Bordet,et al.  Stroke-Induced Brain Parenchymal Injury Drives Blood–Brain Barrier Early Leakage Kinetics: A Combined in Vivo/in Vitro Study , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[35]  D. Zhu,et al.  Neuronal nitric oxide synthase: structure, subcellular localization, regulation, and clinical implications. , 2009, Nitric oxide : biology and chemistry.

[36]  W. Mayhan,et al.  Exercise training normalizes impaired NOS-dependent responses of cerebral arterioles in type 1 diabetic rats. , 2011, American journal of physiology. Heart and circulatory physiology.

[37]  S. Finklestein,et al.  Delayed administration of basic fibroblast growth factor protects against N-methyl-D-aspartate neurotoxicity in neonatal rats. , 1993, European journal of pharmacology.

[38]  M. V. von Herrath,et al.  Mouse Models for Type 1 Diabetes. , 2009, Drug discovery today. Disease models.

[39]  S. Britland,et al.  Relationship of Endoneurial Capillary Abnormalities to Type and Severity of Diabetic Polyneuropathy , 1990, Diabetes.

[40]  N. Toda,et al.  The Pharmacology of Nitric Oxide in the Peripheral Nervous System of Blood Vessels , 2003, Pharmacological Reviews.

[41]  A. Windebank,et al.  Capillary number and percentage closed in human diabetic sural nerve. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[42]  C. Iadecola,et al.  The immunology of stroke: from mechanisms to translation , 2011, Nature Medicine.

[43]  A. Boulton,et al.  Microangiopathy in human diabetic neuropathy: relationship between capillary abnormalities and the severity of neuropathy , 1989, Diabetologia.

[44]  W. Sessa,et al.  erratum: Regulation of endothelium-derived nitric oxide production by the protein kinase Akt , 1999, Nature.

[45]  J. Switzer,et al.  Increased hemorrhagic transformation and altered infarct size and localization after experimental stroke in a rat model type 2 diabetes , 2007, BMC neurology.

[46]  W. Schady,et al.  Endoneurial capillary abnormalities in mild human diabetic neuropathy. , 1992, Journal of neurology, neurosurgery, and psychiatry.